These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. AA amyloidosis: basic knowledge, unmet needs and future treatments. Obici L; Merlini G Swiss Med Wkly; 2012; 142():w13580. PubMed ID: 22653707 [TBL] [Abstract][Full Text] [Related]
3. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis. Nakamura T Mod Rheumatol; 2008; 18(2):109-18. PubMed ID: 18369528 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature. Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866 [TBL] [Abstract][Full Text] [Related]
5. Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis. Ishii W; Matsuda M; Nakamura A; Nakamura N; Suzuki A; Ikeda S Intern Med; 2003 Sep; 42(9):800-5. PubMed ID: 14518665 [TBL] [Abstract][Full Text] [Related]
7. French practical guidelines for the diagnosis and management of AA amyloidosis. Georgin-Lavialle S; Savey L; Buob D; Bastard JP; Fellahi S; Karras A; Boffa JJ; Grateau G; ; Audard V; Bridoux F; Damade R; Deshayes S; Giurgea I; Granel B; Hachulla E; Hot A; Jaccard A; Knebelmann B; Marciano S; Pelcot F; Sarrabay G; Boursier G; Sellam J; Terre A; Bourguiba R Rev Med Interne; 2023 Feb; 44(2):62-71. PubMed ID: 36759076 [TBL] [Abstract][Full Text] [Related]
8. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373 [TBL] [Abstract][Full Text] [Related]
9. [A review for recent advances in AA amyloid research and therapeutic approach to AA amyloidosis complicating rheumatoid arthritis]. Tamura H; Hasegawa K Nihon Rinsho Meneki Gakkai Kaishi; 2009 Feb; 32(1):35-42. PubMed ID: 19252376 [TBL] [Abstract][Full Text] [Related]
10. [Systemic AA amyloidosis induced by benign neoplasms]. Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138 [TBL] [Abstract][Full Text] [Related]
11. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis. Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962 [TBL] [Abstract][Full Text] [Related]
12. Natural history and outcome in systemic AA amyloidosis. Lachmann HJ; Goodman HJ; Gilbertson JA; Gallimore JR; Sabin CA; Gillmore JD; Hawkins PN N Engl J Med; 2007 Jun; 356(23):2361-71. PubMed ID: 17554117 [TBL] [Abstract][Full Text] [Related]
13. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. Liepnieks JJ; Kluve-Beckerman B; Benson MD Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140 [TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis. Westermark GT; Westermark P FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650 [TBL] [Abstract][Full Text] [Related]
15. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report . Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172 [TBL] [Abstract][Full Text] [Related]
16. AA amyloidosis: Mount Sinai experience, 1997-2012. Bunker D; Gorevic P Mt Sinai J Med; 2012; 79(6):749-56. PubMed ID: 23239212 [TBL] [Abstract][Full Text] [Related]
17. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice. Watanabe K; Uchida K; Chambers JK; Ushio N; Nakayama H Vet Pathol; 2017 Jan; 54(1):99-110. PubMed ID: 27565681 [TBL] [Abstract][Full Text] [Related]
18. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis. Nakamura T; Kumon Y; Hirata S; Takaoka H Clin Exp Rheumatol; 2014; 32(4):501-8. PubMed ID: 24959698 [TBL] [Abstract][Full Text] [Related]
19. [Beneficial effect of salazosulfapyridine (SASP) in a patient with secondary renal amyloidosis]. Hidaka M; Ohsawa I; Endo M; Fujita T; Ohi H; Kanmatsuse K; Kusumi Y; Yamaguchi Y Nihon Jinzo Gakkai Shi; 1998 Sep; 40(7):555-9. PubMed ID: 9805922 [TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A1 levels and amyloid deposition following a high-fat diet challenge in transgenic mice overexpressing hepatic serum amyloid A1. Jang WY; Jeong J; Kim S; Kang MC; Sung YH; Choi M; Park SJ; Kim MO; Kim SH; Ryoo ZY Appl Physiol Nutr Metab; 2016 Jun; 41(6):640-8. PubMed ID: 27218680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]